FDA Roundup: May 2, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-may-2-2023

FDA Takes Additional Steps to Advance Decentralized Clinical Trials
http://www.fda.gov/news-events/press-announcements/fda-takes-additional-steps-advance-decentralized-clinical-trials

http://www.fda.gov/medical-devices/medical-device-recalls/avanos-medical-inc-recalls-certain-ballard-access-closed-suction-systems-neonatespediatrics-risk

FDA Conditionally Approves First Drug for Anemia in Cats with Chronic Kidney Disease
http://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-first-drug-anemia-cats-chronic-kidney-disease

FDA Roundup: April 28, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-april-28-2023

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-initiates-voluntary-nationwide-recall-specific-lots-fentanyl-buccal-tablets-cii-due-labeling

FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection
http://www.fda.gov/news-events/press-announcements/fda-approves-first-orally-administered-fecal-microbiota-product-prevention-recurrence-clostridioides

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/akorn-issues-voluntary-nationwide-recall-various-human-and-animal-drug-products-within-expiry-due

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gear-isle-issues-voluntary-nationwide-recall-pro-power-knight-plus-nux-male-enhancement-and-dynamite

FDA Roundup: April 21, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-april-21-2023